Rekha Kumar, MD, Founds head of medical affairs, says that anyone starting medication for a chronic conditionincluding obesity and diabetesshould consider it a long-term commitment
& Yang, G
Meissner WG, Remy P, Giordana C, Maltete D, Derkinderen P, Houeto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carriere N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O, Group LS (2024) Trial of Lixisenatide in early Parkinsons disease
Medical Expert Testimony: Statements from qualified medical professionals who can explain the link between the drug and the patients specific injury
"If someone is experiencing any side effects while taking any Lilly medication, we encourage them to speak with their healthcare provider." Users can also call the The Lilly Answers Center at 1-800-LillyRx
The conclusion about lifestyle intervention is unsubstantiated and its not an sensible message to be sending